THERAPEUTIC CLASS

Use of Diphtheria Antitoxin (DAT) for Suspected Diphtheria Cases IND

---

The purpose of this Investigational New Drug (IND) protocol is to provide access to diphtheria antitoxin (DAT) for emergency treatment of suspected diphtheria cases and, under exceptional circumstances, to provide passive, transient protection against diphtheria toxin in an exposed contact. A FDA-licensed diphtheria antitoxin product is unavailable in the United States.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Allergy & Immune System

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment